Management of Castration-Resistant Prostate Cancer with Oligometastases

NCT02685397 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Castration-resistant Prostate Cancer Patients with Oligometastases

Interventions

DRUG: Leuprolide Acetate
DRUG: Goserelin Acetate
DRUG: Triptorelin
DRUG: Enzalutamide
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

Sir Mortimer B. Davis - Jewish General Hospital